Literature DB >> 3016881

Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.

N Jacobsen, H K Andersen, P Skinhøj, L P Ryder, P Platz, D Jerne, V Faber.   

Abstract

Chronic graft-versus-host disease (GvHD) in bone marrow allograft recipients is frequently preceded by a cytomegalovirus (CMV) infection. To elucidate whether an immune reaction of transplanted donor cells against CMV was involved in the pathogenesis of chronic GvHD, the effect of donor pretransplant CMV immune status on chronic GvHD incidence was analyzed. In 43 bone marrow recipients at risk, the 2-yr cumulative chronic GvHD probability was 55% when the donor was immune, in contrast to 16.5% when the donor was non-immune (p less than 0.002). No correlation between recipient pretransplant CMV immunity and chronic GvHD was observed. Donor CMV immunity did not correlate with acute GvHD or posttranplant CMV infection and seemed to predispose for chronic GvHD regardless of donor and recipient age. However, the proportion of CMV immune donors increased with increasing donor and recipient age. This may account for the higher incidence of chronic GvHD in older patients. The present study suggests that chronic GvHD may be mediated by a reaction of immune donor cells against CMV infected recipient cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016881     DOI: 10.1111/j.1600-0609.1986.tb02287.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  3 in total

1.  Changes in plasma beta 2 microglobulin concentrations after allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M A Forbes; E H Cooper; J A Child
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

Review 2.  Correlation of pretransplant viral serology and complications of bone marrow transplantation.

Authors:  O Ringdén
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

3.  How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?

Authors:  Mohammad Vaezi; Amir Kasaeian; Maryam Souri; Faeze Soufiyan; Amir Shokri Boosjin; Seyed Amin Setarehdan; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.